China Pharma (NYSE:CPHI) Shares Down 3.1% – What’s Next?

Shares of China Pharma Holdings, Inc. (NYSE:CPHI) dropped 3.1% during mid-day trading on Monday . The stock traded as low as $0.73 and last traded at $0.7470. Approximately 56,938 shares traded hands during trading, a decline of 68% from the average session volume of 177,620 shares. The stock had previously closed at $0.7711.

China Pharma Price Performance

The stock has a 50-day moving average price of $0.72 and a 200 day moving average price of $0.88. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. The firm has a market cap of $30.27 million, a price-to-earnings ratio of -1.36 and a beta of 1.16.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in China Pharma stock. Citadel Advisors LLC raised its position in China Pharma Holdings, Inc. (NYSE:CPHI) by 31.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 30,426 shares of the company’s stock after buying an additional 7,356 shares during the quarter. Citadel Advisors LLC owned approximately 0.93% of China Pharma worth $59,000 as of its most recent filing with the Securities and Exchange Commission.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension.